AUB
BIO icon

Atlantic Union Bankshares’s Bio-Rad Laboratories Class A BIO Stock Holding History

Atlantic Union Bankshares’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$969K Sell
3,300
-799
-19% -$227K 0.02% 383
2026
Q1 		$1.14M Hold
4,099
– – 0.02% 349
2025
Q4 		$1.24M Hold
4,099
– – 0.02% 347
2025
Q3 		$1.15M Buy
+4,099
New +$1.12M 0.02% 356

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Atlantic Union Bankshares's BIO Position: Q2 2026 in Review

Atlantic Union Bankshares reduced its Bio-Rad Laboratories Class A (BIO) stake by 19% in Q2 2026, selling an estimated $227K and leaving 3,300 shares worth $969K. The position accounts for 0.02% of the portfolio, ranked #383.

Atlantic Union Bankshares first reported a position in BIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.24M in Q4 2025. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Atlantic Union Bankshares held 3,300 shares of Bio-Rad Laboratories Class A worth $969K as of Q2 2026.
  • Atlantic Union Bankshares sold 799 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $227K.
  • Bio-Rad Laboratories Class A made up 0.02% of Atlantic Union Bankshares's portfolio in Q2 2026, its #383 holding.
  • Atlantic Union Bankshares first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and has held it in 4 quarters since.
  • Atlantic Union Bankshares's Bio-Rad Laboratories Class A position peaked at $1.24M in Q4 2025.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.